These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

423 related articles for article (PubMed ID: 21167036)

  • 1. Inference of hierarchical regulatory network of estrogen-dependent breast cancer through ChIP-based data.
    Gu F; Hsu HK; Hsu PY; Wu J; Ma Y; Parvin J; Huang TH; Jin VX
    BMC Syst Biol; 2010 Dec; 4():170. PubMed ID: 21167036
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A hidden Markov model to identify combinatorial epigenetic regulation patterns for estrogen receptor α target genes.
    Bonneville R; Jin VX
    Bioinformatics; 2013 Jan; 29(1):22-8. PubMed ID: 23104890
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A modulated empirical Bayes model for identifying topological and temporal estrogen receptor α regulatory networks in breast cancer.
    Shen C; Huang Y; Liu Y; Wang G; Zhao Y; Wang Z; Teng M; Wang Y; Flockhart DA; Skaar TC; Yan P; Nephew KP; Huang TH; Li L
    BMC Syst Biol; 2011 May; 5():67. PubMed ID: 21554733
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Transcriptional regulation prediction of antiestrogen resistance in breast cancer based on RNA polymerase II binding data.
    Zhang D; Wang G; Wang Y
    BMC Bioinformatics; 2014; 15 Suppl 2(Suppl 2):S10. PubMed ID: 24564526
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inference of hierarchical regulatory network of TCF7L2 binding sites in MCF7 cell line.
    Wang Y; Wang R; Jin VX
    Int J Comput Biol Drug Des; 2016; 9(1-2):25-53. PubMed ID: 28066512
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cooperativity of co-factor NR2F2 with Pioneer Factors GATA3, FOXA1 in promoting ERα function.
    Jiang G; Wang X; Sheng D; Zhou L; Liu Y; Xu C; Liu S; Zhang J
    Theranostics; 2019; 9(22):6501-6516. PubMed ID: 31588232
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cellular reprogramming by the conjoint action of ERα, FOXA1, and GATA3 to a ligand-inducible growth state.
    Kong SL; Li G; Loh SL; Sung WK; Liu ET
    Mol Syst Biol; 2011 Aug; 7():526. PubMed ID: 21878914
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Unique ERalpha cistromes control cell type-specific gene regulation.
    Krum SA; Miranda-Carboni GA; Lupien M; Eeckhoute J; Carroll JS; Brown M
    Mol Endocrinol; 2008 Nov; 22(11):2393-406. PubMed ID: 18818283
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparative Cistromics Reveals Genomic Cross-talk between FOXA1 and ERα in Tamoxifen-Associated Endometrial Carcinomas.
    Droog M; Nevedomskaya E; Kim Y; Severson T; Flach KD; Opdam M; Schuurman K; Gradowska P; Hauptmann M; Dackus G; Hollema H; Mourits M; Nederlof P; van Boven H; Linn SC; Wessels L; van Leeuwen FE; Zwart W
    Cancer Res; 2016 Jul; 76(13):3773-84. PubMed ID: 27197147
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Global analysis of ZNF217 chromatin occupancy in the breast cancer cell genome reveals an association with ERalpha.
    Frietze S; O'Geen H; Littlepage LE; Simion C; Sweeney CA; Farnham PJ; Krig SR
    BMC Genomics; 2014 Jun; 15(1):520. PubMed ID: 24962896
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Breast tumor specific mutation in GATA3 affects physiological mechanisms regulating transcription factor turnover.
    Adomas AB; Grimm SA; Malone C; Takaku M; Sims JK; Wade PA
    BMC Cancer; 2014 Apr; 14():278. PubMed ID: 24758297
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A hypermethylation strategy utilized by enhancer-bound CARM1 to promote estrogen receptor α-dependent transcriptional activation and breast carcinogenesis.
    Peng BL; Li WJ; Ding JC; He YH; Ran T; Xie BL; Wang ZR; Shen HF; Xiao RQ; Gao WW; Ye TY; Gao X; Liu W
    Theranostics; 2020; 10(8):3451-3473. PubMed ID: 32206101
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A modulator based regulatory network for ERα signaling pathway.
    Wu HY; Zheng P; Jiang G; Liu Y; Nephew KP; Huang TH; Li L
    BMC Genomics; 2012; 13 Suppl 6(Suppl 6):S6. PubMed ID: 23134758
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Functional genomics identifies a mechanism for estrogen activation of the retinoic acid receptor alpha1 gene in breast cancer cells.
    Laganière J; Deblois G; Giguère V
    Mol Endocrinol; 2005 Jun; 19(6):1584-92. PubMed ID: 15831516
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hierarchical modularity in ERα transcriptional network is associated with distinct functions and implicates clinical outcomes.
    Tang B; Hsu HK; Hsu PY; Bonneville R; Chen SS; Huang TH; Jin VX
    Sci Rep; 2012; 2():875. PubMed ID: 23166858
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Estrogen Receptor-β Modulation of the ERα-p53 Loop Regulating Gene Expression, Proliferation, and Apoptosis in Breast Cancer.
    Lu W; Katzenellenbogen BS
    Horm Cancer; 2017 Aug; 8(4):230-242. PubMed ID: 28577282
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prognosis of hormone-dependent breast cancers: implications of the presence of dysfunctional transcriptional networks activated by insulin via the immune transcription factor T-bet.
    McCune K; Bhat-Nakshatri P; Thorat MA; Nephew KP; Badve S; Nakshatri H
    Cancer Res; 2010 Jan; 70(2):685-96. PubMed ID: 20068169
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Estrogen receptor-dependent regulation of CYP2B6 in human breast cancer cells.
    Lo R; Burgoon L; Macpherson L; Ahmed S; Matthews J
    Biochim Biophys Acta; 2010; 1799(5-6):469-79. PubMed ID: 20079471
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Research resource: interplay between the genomic and transcriptional networks of androgen receptor and estrogen receptor α in luminal breast cancer cells.
    Need EF; Selth LA; Harris TJ; Birrell SN; Tilley WD; Buchanan G
    Mol Endocrinol; 2012 Nov; 26(11):1941-52. PubMed ID: 23023562
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Down-regulation of Forkhead box protein A1 (FOXA1) leads to cancer stem cell-like properties in tamoxifen-resistant breast cancer cells through induction of interleukin-6.
    Yamaguchi N; Nakayama Y; Yamaguchi N
    J Biol Chem; 2017 May; 292(20):8136-8148. PubMed ID: 28270510
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.